• The Cost Of Illness Of Atrial Fibrillation In Italy- A Cohort Of Hospitalized Patients

    Nov 1, 2014, 00:00

  • The Impact Of Cardiovascular Disease And Type 2 Diabetes Mellitus On Social Cost In Chronic Kidney Disease Patients In Italy

    Nov 1, 2014, 00:00

  • Local Variation in Primary Care Prescribing Behavior in England- Ticagrelor

    Nov 1, 2014, 00:00

  • Global HTA Assessments of Ultra-Orphan Products- A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase)

    Nov 1, 2014, 00:00

  • Does Blood Lipid Screening is Cost-Effectiveness Among Chinese Adults Aged 45 And Above?

    Nov 1, 2014, 00:00

  • Catastrophic Health Expenditures and Chronic Condition Patients in Greece

    Nov 1, 2014, 00:00

  • Predictions for Medical Subsidy Enrollment Among Young Children From High-Risk Families in Taipei

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Dapagliflozin Compared To Lixisenatide As An Add-On To Insulin In The Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure

    Nov 1, 2014, 00:00

  • First Experiences With The New Testing Examination and Treatment- Methods in Germany- Is This A New Amnog Clone?

    Nov 1, 2014, 00:00

  • The Use and Acceptance of Novel Statistical Analyses To Support Technology Submissions To Hta Authorities

    Nov 1, 2014, 00:00

  • Long-Term Trends in Breast Cancer Epidemiology in the Slovak Republic

    Nov 1, 2014, 00:00

  • A Systematic Review and Network Meta-Analysis of Pharmacological Therapies Used for Patients with Advanced Parkinson's Disease

    Nov 1, 2014, 00:00

  • Feasibility of Pharmacoeconomic Evaluations of Traditional Chinese Medicine from the Perspectives of the Health Insurance Review Assessment Service in South Korea

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Valsartan Versus Olmesartan Addition To Amlodipine And Hydrochlorothiaziade Single-Pill Triple Antihypertensive Therapy

    Nov 1, 2014, 00:00

  • Upfront Overall Survival Modelling in Comparison to Real World Data- Lenalidomide for the Treatment of Multiple Myeloma Patients in South Korea

    Nov 1, 2014, 00:00

  • Study of Technical Conditions for Improvement of Angiographic Image Quality

    Nov 1, 2014, 00:00

  • The Budget Impact Of New Generation Ct Scanners For Difficult-To-Image, Low-Risk Patients With Suspected Cad

    Nov 1, 2014, 00:00

  • Current and Future Costs of Osteoporotic Fractures in the Netherlands

    Nov 1, 2014, 00:00

  • Hand Hygiene Compliance or the Influencing Factors of Efficiency in the Scope of Students

    Nov 1, 2014, 00:00

  • The Proportional Odds Model Is More Efficient Than The Multinomial Logistic Model For Network Meta-Analyses Of Ordered Outcomes

    Nov 1, 2014, 00:00

  • Content Analysis And Effectiveness Of Interventions To Enhance Oral Antidiabetic Drug (Oad) Adherence In Adults With Type 2 Diabetes- A Systematic Review And Meta-Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Study of Enzymatic Replacement Therapies In the Treatment of Gaucherxs Disease On Adults

    Nov 1, 2014, 00:00

  • Opportunity Costs of Implementing Nice Decisions in NHS Wales

    Nov 1, 2014, 00:00

  • Evaluation of Social Welfare Part of Hungarian Drug Provision System

    Nov 1, 2014, 00:00

  • Effectiveness And Costs Of Different Strategies For The Diagnosis Of Stable Coronary Artery Disease Results From The Evinci Study

    Nov 1, 2014, 00:00

  • Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece

    Nov 1, 2014, 00:00

  • Mapping Fact-P To EQ-5D In Metastatic Castration-Resistant Prostate Cancer (MCRPC)- Performance Of A Previously Developed Algorithm When Applied On A Sample With A Different Disease Stage

    Nov 1, 2014, 00:00

  • Patient-Level Estimates of Diabetic Complications on Direct Medical Cost

    Nov 1, 2014, 00:00

  • Investigating the Framing-Effects of Risk Attributes in Discrete Choice Experiments- A Pilot Study

    Nov 1, 2014, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Cerebral Palsy and Other Paralytic Syndromes in Hungary

    Nov 1, 2014, 00:00

  • Insight In Health Care Databases in Asian Pacific Region

    Nov 1, 2014, 00:00

  • Baseline Patient Characteristics of A Prospective Observational Study to Evaluate the Care Map of Women With Postmenopausal Osteoporosis (Pmo) in Switzerland (Campos)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Asthma Management in a Hospital-Based Adult Asthma Clinic in Spain

    Nov 1, 2014, 00:00

  • Development Of A Global Economic Model To Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment

    Nov 1, 2014, 00:00

  • Exploring the Flaws in Clinical Data that Lead to Rejection of Nice Submissions

    Nov 1, 2014, 00:00

  • Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

    Nov 1, 2014, 00:00

  • Accept® Questionnaire- Relation Between Acceptance And Compliance In Liver- And Kidney-Transplanted Patients Converted To Once-Daily Tacrolimus

    Nov 1, 2014, 00:00

  • Long-Term Grading of Health-Related Quality of Life of Care-Needed Elderly- A 2-Yr Follow-Up Study

    Nov 1, 2014, 00:00

  • Health-Economics in Czech Republic- Can Formal Health-Economic Methodology Improve The Quality Of Submitted Analysis?

    Nov 1, 2014, 00:00

  • Sharing of Information Across Studies to Inform Choice of Functional Form When Conducting Parametric Survival Analysis

    Nov 1, 2014, 00:00

  • The Direct Cost of Asthma in Turkey

    Nov 1, 2014, 00:00

  • The Relationship Between Macular Edema and Health Outcomes Among Patients With Diabetes in Western Europe

    Nov 1, 2014, 00:00

  • Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up- Prefer In Af Registry

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness of Counter Matching for Improving the Efficiency of the Nested Case-Control Design in Observational Studies

    Nov 1, 2014, 00:00

  • Burden of Prostate Cancer and Future Need for Health Care Services

    Nov 1, 2014, 00:00

  • A Comparison of Three Language Versions of the EQ-5D-5L Dimension Scales in Singapore

    Nov 1, 2014, 00:00

  • Applicability Of Eunethta Relative Effectiveness Assessment of Pazopanib For National Assessments

    Nov 1, 2014, 00:00

  • The Cost Of Increasing Physical Activity And Decreasing Body Mass Index For Mid-Life African Women

    Nov 1, 2014, 00:00

  • Characteristics of Patients with Pleural Mesothelioma in the Russian Federation

    Nov 1, 2014, 00:00

  • Interventions and Policy Measures in Health Care And Pharmaceutical Sector To Increase Effeciency And Recovery of Greek Health Care System

    Nov 1, 2014, 00:00

  • Future Impact of Dementia on the Caregiver in China

    Nov 1, 2014, 00:00

  • Economic Burden of Burn Injuries in the Netherlands

    Nov 1, 2014, 00:00

  • Methodological Evaluation Of The Impact Of Survival Costs In Oncology Modelling

    Nov 1, 2014, 00:00

  • Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis – A Case Study in Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Managed Entry Agreements in UK, Italy And Spain

    Nov 1, 2014, 00:00

  • Critical Assessment of Cost-Sharing Schemes Using a Simple Modeling Approach

    Nov 1, 2014, 00:00

  • Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology

    Nov 1, 2014, 00:00

  • Prevalence Of Symptoms And Cluster Analysis In Dialysis Patients Using Kdqol-36

    Nov 1, 2014, 00:00

  • Societal Costs and Qol of Children with Adhd and their Parents- a Comparison to a Reference Group from the General Population

    Nov 1, 2014, 00:00

  • Economic Burden of Disease in France In 2012- A Top-Down Allocation of Health Care Expenditure by Disease Based on the French Health insurance Database (SNIIRAM)

    Nov 1, 2014, 00:00

  • Budgetary Implications of Introducing Fluticasone Furoate/Vilanterol for COPD in the UK

    Nov 1, 2014, 00:00

  • Evaluation of Estimators of Treatment Effect in Observational Studies

    Nov 1, 2014, 00:00

  • Effectiveness of Cardiac Resynchronization Therapy in Patients with Mild-Moderate Heart Failure- A Systematic Review and Bayesian Approach Network Meta-Analysis

    Nov 1, 2014, 00:00

  • How The Implementation Of Drug Zero Markup Policy Will Affect Health Care Expenditure In Hospitals- Observation And Prediction Based On Zhejiang Model

    Nov 1, 2014, 00:00

  • Clinical Implementation of Genomic Sequencing in Pediatric Oncology- Identification and Valuation of Resources and Costs Associated with Next-Generation Sequencing

    Nov 1, 2014, 00:00

  • Impact of Medication Adherence by Using Indian Version Compliance Questionnaire Rheumatology (Cqr) and Medication Adherence Report Scale (Mars) Tools on Quality of Life of Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Are Care-Seekers Good Candidates for Subgroups Cost-Effectiveness Analyses?

    Nov 1, 2014, 00:00

  • Increased Bone Mineral Density (Bmd) In Postmenopausal Women With Osteoporosis (Op) Receiving Two Denosumab Injections In Routine Clinical Practice In Bulgaria

    Nov 1, 2014, 00:00

  • First-Line Therapy for Patients With Multiple Myeloma- Direct and Indirect Comparison of Treatment Regimens on the Existing Market

    Nov 1, 2014, 00:00

  • Prevalence of Neuropathic Pain and Its Disease Burden In Korea Patients With Lumbar Spine Surgery

    Nov 1, 2014, 00:00

  • Effectiveness of Montelukast on Asthma Control in Infants- A Claims Data Study

    Nov 1, 2014, 00:00

  • A Novel Broadly Applicable Risk Score for Predicting Mortality of Patients with Circulatory System Diseases within Hospitalization Duration

    Nov 1, 2014, 00:00

  • Burden and Cost of Multiple Chronic Diseases in A Large Cohort of Elderly in Italy

    Nov 1, 2014, 00:00

  • Is Chinese Syndrome Necessary in the Effectiveness Evaluation of Chinese Herbal Formulas?

    Nov 1, 2014, 00:00

  • Cost Per Patient in Non Interventional Studies and Added Value of Direct To Patient Contact Service

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Dolutegravir for HIV Patients in Slovenia

    Nov 1, 2014, 00:00

  • Impact of Omalizumab On All-Cause and Asthma-Related Health Care Resource Utilisation in Patients With Moderate or Severe Persistent Asthma

    Nov 1, 2014, 00:00

  • Closing the Gap- Reduced Delay to Drug Marketing Approval Between The West and Asia

    Nov 1, 2014, 00:00

  • Differential Pharmaceutical Pricing- Are Prices Co-Related With GDP?

    Nov 1, 2014, 00:00

  • Incidence of Drug Related Problem Admissions Emergency Department Visits in a Secondary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Budget Impact on the Use of Pegfilgrastim to Reduce the Febrile Neutropenia During Chemotherapy for Breast Cancer with Moderate Risk Compared to a Standard Therapy

    Nov 1, 2014, 00:00

  • Time to Reimbursement for Oncology Agents from EMA Marketing Authorization to AIFA Approval AS “C(NN)” Class versus. AIFA Approval AS “A” or “H” Class

    Nov 1, 2014, 00:00

  • Determination of Referral Utilization Rate- Linking Households To Health Care System; Kenyan Rural Setting Experience

    Nov 1, 2014, 00:00

  • Off-Label Use of Anticancer Drugs In South Korea

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Use of Barricaid® In Lumbar Discectomy Surgery in Turkey

    Nov 1, 2014, 00:00

  • Access to Asthma Medicines in Tehran; Iran

    Nov 1, 2014, 00:00

  • Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3

    Nov 1, 2014, 00:00

  • The Economic Burden and their Predictors in Preschool Children with Dental Caries in Urban Beijing

    Nov 1, 2014, 00:00

  • Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain

    Nov 1, 2014, 00:00

  • Health Economics Evaluation for Insulin Injection Pen-Needle with Different Lengths in Patients With Diabetes in China

    Nov 1, 2014, 00:00

  • An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

    Nov 1, 2014, 00:00

  • Price Control Of Out-Patient Cancer Drugs In Bulgaria, 2010-2011- Reference Based Pricing And Public Tenders Verse Reference Based Pricing Only

    Nov 1, 2014, 00:00

  • Health Care Utilization and Cost Comparison Between Adherent Hypertension Patients Treated by Single Exforge HCT and Amlodipine/Valsartan/Hydrochlorothiazide Free Combination

    Nov 1, 2014, 00:00

  • The Budget Impact of Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbohaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in the United Kingdom- Impact on Health Care Co ...

    Nov 1, 2014, 00:00

  • Cost-Benefit Assessment of the Electronic Health Records for Clinical Research (EHR4CR) European Project

    Nov 1, 2014, 00:00

  • Brio- A European Prospective Observational Study to Assess the Burden of Disease and Treatment in Metastatic Breast Cancer (Mbc) Patients Treated with Oral Vinorelbine (Nvboral) or Intravenous Vinorelbine (Ivvino)

    Nov 1, 2014, 00:00

  • The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS)

    Nov 1, 2014, 00:00

  • Potential Monetary Value of Human Papillomavirus Vaccination on Human Papillomavirus-Related Cancers and Genital Warts in the United Kingdom

    Nov 1, 2014, 00:00

  • Use Of Model Averaging Techniques in Cost-Effectiveness Analysis in Oncology

    Nov 1, 2014, 00:00

  • Importance Of Remission In Patients With Major Depressive Disorder In Korea For Improving Health-Related Quality Of Life And Economic Burden

    Nov 1, 2014, 00:00

  • Adherence, Predicting Factors and Satisfaction of Patients on Glaucoma Therapy- Findings From a Cross-Sectional Study in Korea

    Nov 1, 2014, 00:00

  • Prevalence of Febrile Neutropenia in Breast Cancer Patients Received Adjuvant Paclitaxel Treatment

    Nov 1, 2014, 00:00

  • Health Care Cost Associated To Constipation Predominant Irritable Bowel Syndrome In Spain

    Nov 1, 2014, 00:00

  • HBA1C Control Predictive Validity of Four Self-Reported Measures of Antidiabetes Medication Adherence

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of 10- and 13-Valent Pneumocococcal Conjugate Vaccines in the Philippines

    Nov 1, 2014, 00:00

  • Using The Ispor 2013 European Congress as a Big Data Case Study

    Nov 1, 2014, 00:00

  • Predictors Pf Remission in the Treatment of Depression in the Middle East- Real-World Evidence From A 6-Month Prospective Observational Study

    Nov 1, 2014, 00:00

  • Impact of Non-Consented Switch and Subsequent Switch in Asthma Medication- Qualitative Study of Patient Perspective in the UK

    Nov 1, 2014, 00:00

  • Cost of Treating Hip Fractures With Cephalomedullary Nails- A Retrospective Claims Database Review

    Nov 1, 2014, 00:00

  • Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc)- A Cost Utility Analysis from a Chinese Health Care Perspective

    Nov 1, 2014, 00:00

  • Predictors of German Amnog Decisions and GKV Rebate Negotiations- A Database Analysis

    Nov 1, 2014, 00:00

  • Cost Effectiveness 0f Propofol Verses Thiopental in Icu Wards

    Nov 1, 2014, 00:00

  • Treatment Patterns And Outcomes Of Patients Diagnosed With Ovarian Cancer In The Netherlands- A Registry Study

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Panitumumab+Mfolfox over Bevacizumab+Mfolfox as a First-Line Treatment for Metastatic Colorectal Cancer Patients with Wild-Type Ras in Greece

    Nov 1, 2014, 00:00

  • The Use of Real World Data in the Decision-Making Process- An Example Using Blood Glucose Test Strip Use In Patients With Type 2 Diabetes In Ireland

    Nov 1, 2014, 00:00

  • Research Prioritization In An Mcda Context- Existing Methods - New Results

    Nov 1, 2014, 00:00

  • The Use of Integrated Concept Mapping to Develop the Dementia Care Model by Community Participation

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Korea

    Nov 1, 2014, 00:00

  • Clinical Characteristics Among Hypertension Patients with Diabetes in Shanghai, China

    Nov 1, 2014, 00:00

  • Single-ARM Studies to Support Drug Reimbursement in Australia

    Nov 1, 2014, 00:00

  • Prescription Practices for Uncomplicated Malaria at two Public Health Facilities in Nigeria; A Descriptive, Comparative Study

    Nov 1, 2014, 00:00

  • BCEA- A R Package to Perform Bayesian Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel and Capecitabine Plus Docetaxel in Metastatic Breast Cancer Patients in Egypt

    Nov 1, 2014, 00:00

  • Evaluation of Selected Ken-Drgs in Greek Public Hospitals- The Degree to Which they Reflect Actual Expenditure and Average Length of Stay

    Nov 1, 2014, 00:00

  • Application of A Model Of Decision Based on Fuzzy Logic to Pharmacoeconomics- Treatment of CROHN'S Disease With Antitnf in Out of Label Use

    Nov 1, 2014, 00:00

  • Estimating The Impact Of Expanding Access To Celecoxib For Osteoarthritis Patients In China

    Nov 1, 2014, 00:00

  • The Analysis of Dental Care in Ukraine at the Regional Level

    Nov 1, 2014, 00:00

  • Pricing and Reimbursement Policy Updates in Asia

    Nov 1, 2014, 00:00

  • Carer Perceived Burden as a Predictor of Health-Related Quality of Life- The Case of Colorectal Cancer

    Nov 1, 2014, 00:00

  • Comparative Analysis of Hta Decisions, Price and Reimbursement Level of Orphan Drugs In France and Italy

    Nov 1, 2014, 00:00

  • An Analysis of the Key Value Drivers for HTA Assessments In Taiwan

    Nov 1, 2014, 00:00

  • Cerebrospinal Fluid ƒ"-Amyloid1-42 Levels in the Differential Diagnosis of Alzheimer's Disease - Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis of Oral Capecitabine and Tegafur for Colorectal Cancer Treatment in Russia

    Nov 1, 2014, 00:00

  • Burden of Wet Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • The Value of Diagnostic Tests for Alzheimer's Disease- Discrete-Choice Experiment and Contingent-Valuation

    Nov 1, 2014, 00:00

  • Efficacy of Ayurvedic Formulation in The Management of Essential Hypertension

    Nov 1, 2014, 00:00

  • Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) In Portugal

    Nov 1, 2014, 00:00

  • Nurses' Perception Towards the Benefits of Pharmaceutical Care Services in Tertiary Health Care Settings Pakistan- A Qualitative Insight

    Nov 1, 2014, 00:00

  • Metastatic Prostate Cancer and Skeletal Related Events, a Cost of Illness Study

    Nov 1, 2014, 00:00

  • Innovation May Drive Streamlined Access to New Biopharmaceuticals Across Some Emea Markets

    Nov 1, 2014, 00:00

  • TC-325 in the Management of Upper and Lower GI Bleeding- A Two-Year Experience at a Single Institution

    Nov 1, 2014, 00:00

  • Are “Lively” and “Full of Pep” Similar Or Different Concepts? Challenges in Translating These Terms in Seven Languages

    Nov 1, 2014, 00:00

  • Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension- Impact Of Age And Cardiovascular Risk Factors

    Nov 1, 2014, 00:00

  • The Impact of Treatment of Thyreoid Disease in Pregnant Women to the Outcome of Giving Birth

    Nov 1, 2014, 00:00

  • Cost Consequence Comparison Of Hemostatic Matrix Agents

    Nov 1, 2014, 00:00

  • Assessment of Lung Cancer Treatment by Disease Phase Using National Cancer Registry Data Linked with Treatment Pathway cost Data in Austria

    Nov 1, 2014, 00:00

  • The Economic Impact Of Hypertension In Health Care System Of Pakistan

    Nov 1, 2014, 00:00

  • Comparing the Efficacy of Anti-Vascular Endothelia Growth Factor Drugs for Treatment of Age-Related Macular Degeneration- a Clinical Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • A Comparative Analysis on The Reimbursement Status Of Sensor Augmented Pump Therapy in Turkey and Other Selected Countries

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Coffee Consumption for Prevention of All-Cause Mortality in Germany

    Nov 1, 2014, 00:00

  • Risk Factors Associated With Venous Thromboembolism Recurrence In A European Population

    Nov 1, 2014, 00:00

  • Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practi Insights-Ipf Registry

    Nov 1, 2014, 00:00

  • Cost-Consequences Analysis of the Long-Term Prophylaxis In A Type 1 Von Willebrand Disease Patient With Recurrent Bleedings In Italy

    Nov 1, 2014, 00:00

  • Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

    Nov 1, 2014, 00:00

  • Saudi Arabia- A very Attractive Biopharmaceutical Market, Once Manufacturers Can Navigate the Labyrinth

    Nov 1, 2014, 00:00

  • Assessment Of The Impact Of Legislation On The Utilization Of Statins In Slovakia

    Nov 1, 2014, 00:00

  • Results of Comparative Study of Macrolide Group Antibiotics Consumption in Ukraine, Russia and Kazakhstan

    Nov 1, 2014, 00:00

  • Comparing the Use of Patient-Level Data to An Average Patient Profile Within a Type 2 Diabetes Simulation Model

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes Assessed Using the Breast-Q Instrument in Women Undergoing Breast Reconstruction Post-Mastectomy- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Patient, Insuree and Public Participation in Health Technology Assessment- An International Comparison

    Nov 1, 2014, 00:00

  • Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in C ...

    Nov 1, 2014, 00:00

  • Retrospective Analysis of the Economic Burden of Long-Term Care Facility Residents Diagnosed With Alzheimer's Disease in the United States

    Nov 1, 2014, 00:00

  • A Systematic Review To Identify the Use of Preference Elicitation Methods in Health Care Decision Making

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Carotid Artery Stenting Versus Endarterectomy For Symptomatic Carotid Stenosis Patients

    Nov 1, 2014, 00:00

  • Factors Affecting the Out-Come in Hospital Acquired Pneumonia

    Nov 1, 2014, 00:00

  • The Pharmacoeconomics Review of 7-Valent Pneumococcal Conjugate Vaccination in Asian-Pacific Region

    Nov 1, 2014, 00:00

  • Cachexia in the Us Health Care System

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Ranolazine For The Treatment Of Angina Pectoris In Russia

    Nov 1, 2014, 00:00

  • Strengthening Evidence Base for Traditional Medicine in Asean, Quality of Reporting of Randomised Controlled Trials of Herbal Interventions in Asean Plus Six Countries- A Systematic Review

    Nov 1, 2014, 00:00

  • Assessment of KAP Among Hospital Pharmacists

    Nov 1, 2014, 00:00

  • Use of Hospital Services by HIV Patients, 2012

    Nov 1, 2014, 00:00

  • Clinical Trial Activity in Greece From 2010 To 2012- Still Missing the Opportunities?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of First-Line Therapy For Advanced Non-Small Cell Lung Cancer (Nsclc)

    Nov 1, 2014, 00:00

  • Prescribing Pattern and Cost Analysis on (Dmard's) Disease Modifying Anti Rheumatoid Drugs in Rheumatoid Arthritis Patients of a Tertiary Care Teaching Hospital in South India – a Cross Sectional Study

    Nov 1, 2014, 00:00

  • Pricing and Reimbursement Environment For A Biologic Obtaining A Licence In A Second Indication in Key European Countries

    Nov 1, 2014, 00:00

  • Evaluation of the Burden of Illness of u. S. Medicare Patients Diagnosed with Hyperpotassemia

    Nov 1, 2014, 00:00

  • Medication Usage Pattern, Health Resource Utilization and Economic Burden for Patients with Mdd in Beijing, China

    Nov 1, 2014, 00:00

  • Direct Costs Of Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • A Guideline-Based Estimate of Health Care Resource Use and Cost of Metastatic Unresectable Osteosarcoma

    Nov 1, 2014, 00:00

  • Comparison of Disease Status and Outcomes of Patients With Ankylosing Spondylitis (As) Receiving Adalimumab Or Etanercept Monotherapy In Europe

    Nov 1, 2014, 00:00

  • Using Transmission Dynamic Model to Determine Vaccination Coverage Rate Based on Economic Burden of Infectious Disease- An Example of Pneumococcus Vaccine

    Nov 1, 2014, 00:00

  • Epidemiological and Financial Burden of Preterm Labor Hospitalizations – An Analysis of German Claims Data

    Nov 1, 2014, 00:00

  • How Can the Quality of Life in Hand Eczema Questionnaire (qolheq) be Interpreted? A Banding Study

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey

    Nov 1, 2014, 00:00

  • Biosimilars Versus Brands for Rheumatoid Arthritis- Eu5 Payers and Prescribers Place their Bets

    Nov 1, 2014, 00:00

  • Epidemiology and Costs of Varicella and Herpes Zoster in Germany

    Nov 1, 2014, 00:00

  • Incidence and Long-Term Cost of Oral Steroid-Related Adverse Events in Chronic Diseases in Poland

    Nov 1, 2014, 00:00

  • Analysing The Effects of a Disinvestment Decision in Breast Cancer Screening Programmes in Asia-Pacific Countries- A Modelling Approach

    Nov 1, 2014, 00:00

  • What Could the Future Hold? Simulating the Demand for Osteoarthritis (oa) Care in Alberta to Plan a Sustainable Oa Care System

    Nov 1, 2014, 00:00

  • Buget Impact Analysis of Rituximab for Chronic Lymphocytic Leukemic- The Case of Brazilian Public Health

    Nov 1, 2014, 00:00

  • The DA Vinci Surgical System- A Rapid Review of the Clinical and Economic Evidence

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis of Flash Glucose Monitoring for Type 2 Diabetes Patients Receiving Insulin Treatment In The Uk

    Nov 1, 2014, 00:00

  • Coronary And Cardiovascular Disease Risks In Migraine Patients- Evidence From National Health And Nutrition Examination Survey 1999–2004

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Use of Gefitinib for the Treatment of Locally Advanced or Metastatic NSCLC

    Nov 1, 2014, 00:00

  • Clusters of Health-States Valuations

    Nov 1, 2014, 00:00

  • Stratified Cost-Effectiveness Analysis To Guide Genetic Screening For Cancer Risk

    Nov 1, 2014, 00:00

  • Potential Risk-Sharing Agreements for Vaccines

    Nov 1, 2014, 00:00

  • The Cost Effectiveness Analysis Of The Oral Anti-Viral Treatments Alternatives For The Chronic Hepatitis B In Turkey

    Nov 1, 2014, 00:00

  • Cost of Influenza and Acute Respiratory Infections Treatment in Ukraine

    Nov 1, 2014, 00:00

  • The Costs of Illness of Atopic Dermatitis in South Korea

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Trastuzumab in Treatment Of Metastatic Her2-Positive Breast Cancer in Vietnam

    Nov 1, 2014, 00:00

  • Using Hormonal Contraception Reduce Unintended Pregnancy in China

    Nov 1, 2014, 00:00

  • Economic Evaluation of Primary Prophylaxis Using Filgrastim Versus Pegfilgrastim in Patients With Solid Tumor Cancer- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Assessment Of The Huntington Clinical Self-Reported Instrument (H-CSRI) Cross-Cultural Validity

    Nov 1, 2014, 00:00

  • Patients And Doctors Working Together To Improve Health Servi Difficulties And Challenges In Between In China

    Nov 1, 2014, 00:00

  • Impact of Biologics Use on Depression and Anxiety Frequency and Health Care Resource Utilization In Psoriasis- An Analysis Using the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2014, 00:00

  • Novel Imaging Technology To Select Patients For Individualized Therapies- Test Performance And Cost-Effectiveness

    Nov 1, 2014, 00:00

  • How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

    Nov 1, 2014, 00:00

  • Clinical Outcomes and Health Care Resource Utilization in a 1-Year Observational Study of Patients with Non-focal Disabling Spasticity who are Resistant or Intolerant to Oral Therapy Treated with Intrathecal Baclofen Therapy at the Institut ...

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Benefit of Positive Airway Pressure (PAP) Therapy in Sleep Apnoea (SA) Patients With Chronic Obstructive Pulmonary Disease (COPD) in Germany- A Retrospective Comparative Cohort Analysis Based on a Statutory Health Insurance Database

    Nov 1, 2014, 00:00

  • National Immunisation Technical Advisory Groups - A Framework For Assessment and Insights From Research

    Nov 1, 2014, 00:00

  • Corrective Estimation of New Cases of Hepatitis C Infections in China Between 2005 and 2013

    Nov 1, 2014, 00:00

  • Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)

    Nov 1, 2014, 00:00

  • Episodes of Care and their Costs Based on ICPC-2 Classification- Three Month Follow-Up Study in Finland

    Nov 1, 2014, 00:00

  • Cost Estimation Of Home Blood Pressure Monitoring Versus Combined Office And Ambulatory Measurements In Hypertension Management

    Nov 1, 2014, 00:00

  • The Growing Financial and Quality-of-Life Burden Associated With Atrial Fibrillation (Af), Diabetes, Chronic Obstructive Pulmonary Disease (Copd) And Asthma in Ireland

    Nov 1, 2014, 00:00

  • Describing the Health Status of Schizophrenia Caregivers in the 5E.U

    Nov 1, 2014, 00:00

  • Efficacy of The Automated Target Glucose Control- A Systematic Review

    Nov 1, 2014, 00:00

  • Systematic Review of Relapsed or Refractory Mantle Cell Lymphoma (MCL) Clinical Trials- Implications for Decision Modeling

    Nov 1, 2014, 00:00

  • Study on Audit and Control System and its Current Situation

    Nov 1, 2014, 00:00

  • Systematic Literature Review and Mixed Treatment Comparison of Gxr Versus other Treatments in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2014, 00:00

  • Research Presentations Financial Disclosure Statements ISPOR 6th Asia-Pacific Conference Abstracts

    Nov 1, 2014, 00:00

  • Burden of Influenza B in 9 European Countries- A Literature Review

    Nov 1, 2014, 00:00

  • Factors Influencing Dutch Drug Reimbursement Recommendations; A Database Analysis

    Nov 1, 2014, 00:00

  • Treatments for EGFR Mutation-Positive (M+) NSCLC Patients – A Network Meta-Analysis (NMA) by Mutation Type

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Mirabegron 50mg Compared To Tolterodine Er 4mg In The Treatment Of Patients With Overactive Bladder In Canada

    Nov 1, 2014, 00:00

  • Comparability of Interview and Self-Administration of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (Facit-Tb) Instrument in Iraqi Pulmonary Tuberculosis Patients

    Nov 1, 2014, 00:00

  • Predicting Suicidal Behavior In Veterans And Active Military Personnel- Possibilities For Electronic Deployment To Discover A Predictive Assessment

    Nov 1, 2014, 00:00

  • Challenges In Recruiting Patients For The Linguistic Validation Of Pro Instruments Developed For Rare Diseases- A Case Study With Alagille Syndrome

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medicines and Potential Prescribing Omissions in Older People and Their Association With Health Care Utilization- A Retrospective Cohort Study

    Nov 1, 2014, 00:00

  • Can A Global Value Dossier Meet Headquarters and Affiliates's Expectations?

    Nov 1, 2014, 00:00

  • Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT)

    Nov 1, 2014, 00:00

  • Systematic Overview On Value-Of Information Analyses In Cancer Research

    Nov 1, 2014, 00:00

  • Methodological Assessment of Matching-Adjusted Indirect Comparisons- Case Study Application To Attention Deficit/Hyperactivity Disorder (Adhd)

    Nov 1, 2014, 00:00

  • Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden

    Nov 1, 2014, 00:00

  • A Comprehensive Literature Review of the Burden of Gaucher Disease

    Nov 1, 2014, 00:00

  • Cost Analysis Of Pharmaceutical Service In Hospital- A Case Study In A Tertiary Hospital In Sichuan, China

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Comparing Propranolol With Corticosteroids in the Treatment of Proliferating Infantile Hemangioma in Italy

    Nov 1, 2014, 00:00

  • Patient and Disease Characteristics are Important Determinants of Health-Related Quality of Life of Patients with Metastatic Renal Cell Carcinoma Results from a Population-Based Registry

    Nov 1, 2014, 00:00

  • A Comparison of Additional Benefit Scores in Germany (Gba) and France (Has)

    Nov 1, 2014, 00:00

  • Value of Life and Cost of Pre-Mature Deaths With The Perspective of Productivity As Net Tax Revenue- A Comparison in France, Germany, Italy, Spain, United Kingdom

    Nov 1, 2014, 00:00

  • Trends In Prescription Opiate Use Among Patients With Commercial Or Government Sponsored Health Insurance In the Us From 2010-2013

    Nov 1, 2014, 00:00

  • Six Years Of Incretin-Based Agents in Diabetes 2nd Type Treatment in the Czech Republic- The Utilization And Expenditure

    Nov 1, 2014, 00:00

  • Evaluating the Economic Burden and Health Care Utilizations of U. S. Veteran Patients Diagnosed with Chronic Hepatitis C

    Nov 1, 2014, 00:00

  • Evaluation of Patient and Financial Outcomes Associated With Advanced Infertility Treatment Options

    Nov 1, 2014, 00:00

  • The statistical analysis of delayed effects in survival outcomes for immunotherapies. Estimation of time-delay and application of weighted log rank

    Nov 1, 2014, 00:00

  • Health Economic Impact of Bariatric Surgery Revisted- Structured Review of Literature and Health Technology Assessments

    Nov 1, 2014, 00:00

  • Pharmaceutical Pricing and Market Competition- An Empirical Study Based on Anti-Infective Drugs In Tianjin, China

    Nov 1, 2014, 00:00

  • Orphan Drug Policy- Approaches To Market Access In Multiple Countries

    Nov 1, 2014, 00:00

  • Impact of Allergen Immunotherapy on Symptom-Free Days and Health Care Costs in Patients With Grass Pollen-Induced Allergic Rhinitis in Germany

    Nov 1, 2014, 00:00

  • Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Economic Burden of Melanoma in Three European Countries- A Retrospective Observational Study

    Nov 1, 2014, 00:00

  • Estimation of Economic Losses Resulting from Diseases Associated with Smoking in Mexican Insured and Uninsured Population

    Nov 1, 2014, 00:00

  • Hospitalization Costs For Community-Acquired Pneumonia In Elderly In The Netherlands

    Nov 1, 2014, 00:00

  • Patient Reported Outcomes and Their Relevance in Reimbursement Decisions

    Nov 1, 2014, 00:00

  • Epidemiology of Multiple Sclerosis in Latin America- Critical Analysis of the Literature

    Nov 1, 2014, 00:00

  • Coverage or Efficacy- Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy?

    Nov 1, 2014, 00:00

  • Endpoints in Pain- the Suitability for Health Economic Evaluation of Endpoint Designs in Chronic Pain Studies

    Nov 1, 2014, 00:00

  • Budget Impact and Incremental Survival Benefit of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Brazil

    Nov 1, 2014, 00:00

  • The Move Towards Full Implementation Of The Nice Guidelines For Stroke Prevention In Atrial Fibrillation- The Potential Cost And Clinical Impact

    Nov 1, 2014, 00:00

  • Amending the Guide to Methods of Technology Appraisal at Nice to Incorporate two New Value Elements- Burden of Illness And Wider Societal Impact

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Cervical Cancer Screening and Human Papilloma Virus Vaccination In the Philippines

    Nov 1, 2014, 00:00

  • Analysis of New Model of Therapeutic Positioning Reports As A PR Decision-Making Tool in Spain

    Nov 1, 2014, 00:00

  • Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observe ...

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece

    Nov 1, 2014, 00:00

  • Drug Utilisation in Cardiovascular Diseases Management in Slovakia- 8 Years Overview

    Nov 1, 2014, 00:00

  • Multimorbidity Pharmaceutical Cost of Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Missing data Analysis in Longitudinal Studies- Findings from a Quality of Life Study in Malaysian Tuberculosis Patients

    Nov 1, 2014, 00:00

  • Association Between Baseline Socio-Demographic and Clinical Characteristics and Total Annual Cost of Patients Subjected to CRMDS Implantation

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke in China

    Nov 1, 2014, 00:00

  • Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy

    Nov 1, 2014, 00:00

  • (Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy- Study Protocol of A Dutch Randomized Controlled Trial

    Nov 1, 2014, 00:00

  • An Evaluation of Patient Satisfaction In Pafos, Cyprus With The “Europep” Instrument

    Nov 1, 2014, 00:00

  • Responsiveness and Minimal Clinically Important Difference of A Specific Health Related Quality of Life (Hrqol) Questionnaire for Home Enteral Nutrition (Hen) Patients- Nutriqol® Questionnaire

    Nov 1, 2014, 00:00

  • Cost of Illness Analysis of Duchenne Muscular Dystrophy In Italy

    Nov 1, 2014, 00:00

  • Economic Burden of Schizophrenia in China- Based on Medical Insurance Database from Guangzhou City

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Emergency Hormonal Contraception With Ulipristal Acetate Versus Levonorgestrel for Minors in France

    Nov 1, 2014, 00:00

  • Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States

    Nov 1, 2014, 00:00

  • Feasibility of the Headroom Analysis in Early Economic Evaluation of Innovative Diagnostic Technologies With no Immediate Treatment Implications

    Nov 1, 2014, 00:00

  • Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue- A Comparison In Argentina, Brazil And Mexico

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Sofosbuvir For Treatment Of Genotype2 Chronic Hepatitis C In Japan

    Nov 1, 2014, 00:00

  • Diagnostic Tests Of Blood Glucose- A Systematic Review

    Nov 1, 2014, 00:00

  • Switching Patients With Primary Antibody Deficiencies to Home-Based Subcutaneous Immunoglobulin- Economic Evaluation of An Interprofessional Drug Therapy Management Program

    Nov 1, 2014, 00:00

  • A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study

    Nov 1, 2014, 00:00

  • Acute Ischemic Stroke (Ais) Patient Management in French Stroke Units and Impact Estimation of Thrombolysis On Care Pathways and Associated Costs

    Nov 1, 2014, 00:00

  • Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

    Nov 1, 2014, 00:00

  • Partial Reimbursement of Antiviral Agents for HBV- Impact on Antiviral Utilization and Compliance

    Nov 1, 2014, 00:00

  • Real World Data (Rwd) At T=4 in the Netherlands

    Nov 1, 2014, 00:00

  • Regional Assessment of Severe Hypoglycemic Coma Events in Finland

    Nov 1, 2014, 00:00

  • Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective

    Nov 1, 2014, 00:00

  • Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer

    Nov 1, 2014, 00:00

  • Factors Associated with Hospitalization of Type 2 Diabetic Patients with Hypoglycemic Episodes Assisted at Emergency Departments

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer

    Nov 1, 2014, 00:00

  • Pharmacological Basis for the Medicinal use of Almonds in Cardiovascular Disorders

    Nov 1, 2014, 00:00

  • Pattern of Benzodiazepines Utilization In Outpatients With Hypertension in Serbia

    Nov 1, 2014, 00:00

  • Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS

    Nov 1, 2014, 00:00

  • The Cost of NSCLC Treatment in Three Countries- France, Germany and UK

    Nov 1, 2014, 00:00

  • Methods To Elicit Patient Preferences- A Case Study In Metastatic Breast Cancer

    Nov 1, 2014, 00:00

  • Cost Of Bleeding In Complex Cardiac Surgery

    Nov 1, 2014, 00:00

  • Evaluation of a Multidisciplinary Home-Based Medication Review Program for Elderly Singaporeans

    Nov 1, 2014, 00:00

  • Prevalence of Cystic Fibrosis Among the U. S. National Medicaid Population

    Nov 1, 2014, 00:00

  • Treatment Patterns Among Heart Failure Patients Within 30 Days Post Diagnosis- Results From A Us Claims Database Analysis

    Nov 1, 2014, 00:00

  • Effect of Oral Nutritional Supplements On Hospital Outcomes in Patients Aged 65+ With Congestive Heart Failure

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic

    Nov 1, 2014, 00:00

  • Assessing Heterogeneity of Treatment Effect Using Real World Data

    Nov 1, 2014, 00:00

  • Tecepoc II Study. How to Improve the Inhalation Techniques in Patient with Copd. The Influence of Preferences

    Nov 1, 2014, 00:00

  • Systemic Treatment of Metachronous Metastases After Curative Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • Retrospective Analysis On Hospitalization And Health Care Costs, According To Serum Uric Acid Levels In Patients From A Sample Of Italian Local Health Units

    Nov 1, 2014, 00:00

  • Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain

    Nov 1, 2014, 00:00

  • The Impact of Mutliple Sclerosis Severity on Quality of Life, Stress, Depression and Social Support Needs

    Nov 1, 2014, 00:00

  • Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

    Nov 1, 2014, 00:00

  • Impact of Early Microbiologic Culture in the Economic Burden of Care for Patients With Infected Diabetic Foot Ulcers At A Model Of Secondary Level Imss' Hospitals in Mexico

    Nov 1, 2014, 00:00

  • A De-Novo Economic Model to Assess Clinical and Economic Consequences of Bronchiectasis

    Nov 1, 2014, 00:00

  • Health Utility Of Acute Coronary Syndrome Patients From An Asian Population

    Nov 1, 2014, 00:00

  • A Review of The Utility Values Used in Published Cost-Effectiveness Analyses of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy in Patients With Diabetic Nephropathy

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Latanoprost Compared with Dorzolamide/Timolol Fixed Combination for the Treatment of Open-Angle Glaucoma and Ocular Hypertension Patients in Korea

    Nov 1, 2014, 00:00

  • Association of Hypoglycemia With Different Oral Antidiabetic Treatments and Its Impact on Quality of Life and Disease Control In Patients With Type 2 Diabetes Mellitus (The Hypo Study)

    Nov 1, 2014, 00:00

  • Layering Interventions for Type-2 Diabetes Prevention Using The Sphr Diabetes Model

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Four Chinese Patent Medicine in the Treatment of Angina Pectoris in China

    Nov 1, 2014, 00:00

  • Efficacy of Virtual Reality Exposure Therapy in the Management of Symptoms Associated With Post Traumatic Stress Disorder

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Saxagliptin Compared to Sitagliptin And Linagliptin As Triple Therapy In Combination With Metformin And A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Comparison on the Concept of Market Access of China and Western Countries

    Nov 1, 2014, 00:00

  • An Ecological Analysis on National Trends and Correlation Between Public Funding for Pneumococcal Vaccination and Pneumonia Disease Burden in the Japanese Elderly Population, 2005-2012

    Nov 1, 2014, 00:00

  • Challenges- in Implementing HTA In The Reimbursement Decisions In Algeria / A Compartive Analysis

    Nov 1, 2014, 00:00

  • Health Literacy and Health Care Utilization Among Adults with Osteoporosis

    Nov 1, 2014, 00:00

  • Hta In The Brazilian Health Care System and Potential Lessons Learned For Other Brics States

    Nov 1, 2014, 00:00

  • Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

    Nov 1, 2014, 00:00

  • Challenges In Meeting Evidence Needs Of Payer, Physician, Patient And Industry Stakeholders For Novel Therapeutics

    Nov 1, 2014, 00:00

  • The Impact on Drug Price and Patiet Selection of National Essential Drug System- Evidence From Inpatient Records from Insurance Reimbursement Data

    Nov 1, 2014, 00:00

  • Budgetary Implications of Introducing Fluticasone Furoate/Vilanterol for Asthma in the UK

    Nov 1, 2014, 00:00

  • The Future of Education In HTA and Health Economics

    Nov 1, 2014, 00:00

  • Identifying the Broader Value of Vaccines in Low and Middle Income Countries

    Nov 1, 2014, 00:00

  • Patients' Preferences in Late Stage Treatment of Non-Small-Cell Lung Cancer- A Discrete-Choice Experiment

    Nov 1, 2014, 00:00

  • Detection and Evaluation of the Medication Errors in Different Hospitals in Province of the Punjab, Pakistan

    Nov 1, 2014, 00:00

  • Third Party Participation in Early Benefit Assessment of Cancer Drugs in Germany

    Nov 1, 2014, 00:00

  • New Reimbursement Schemes for Stratified Medicine in Oncology – A Systematic Review

    Nov 1, 2014, 00:00

  • Adherence To Anticoagulant Therapy In Children Hospitalized for Pulmonary Embolism and Deep Vein Thrombosis

    Nov 1, 2014, 00:00

  • Exposure To Potential Drug-Drug Interactions in Teaching Hospital Of South Punjab, Pakistan

    Nov 1, 2014, 00:00

  • A Tutorial on Dimensionality Reduction in Large Claims Data Sets

    Nov 1, 2014, 00:00

  • Trends of Hypnotic Medication Use in A 2000-Bed Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • Outpatient Treatment of Adolescents in Japan with Drugs for Attention Deficit Disorders

    Nov 1, 2014, 00:00

  • Exploring the Willingness-to-Pay for Innovative Treatments for Immunology and Oncology in China

    Nov 1, 2014, 00:00

  • Effect of Health Education Program on Knowledge, Attitude, Practice and Health Related Quality of Life in Hepatitis-B Patients

    Nov 1, 2014, 00:00

  • Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis Tofacitinib Use in Rheumatoid Arthritis Treatment Scheme

    Nov 1, 2014, 00:00

  • Utility Values Among Myopic Patients in Mainland China

    Nov 1, 2014, 00:00

  • The Association of Hosptial Type and Stroke Centre With Mortality, Length of Stay and Hospital Cost of Ischemic Stroke Patients in Alberta

    Nov 1, 2014, 00:00

  • Cost Of Bleeding In Trauma Patients

    Nov 1, 2014, 00:00

  • Acute Myeloid Leukemia and Myelodisplasic Syndrome Treated With Intensive Chemotherapy In France Based On National Hospital Databases (Pmsi)

    Nov 1, 2014, 00:00

  • The Effect of Attention-Deficit/Hyperactivity Disorder on Functioning and Resource Utilization by Psychiatric Outpatients in Europe

    Nov 1, 2014, 00:00

  • Multicriteria Decision Analysis (MCDA) In HTA – Pilot Study in the Czech Republic

    Nov 1, 2014, 00:00

  • The Multicentric Castleman's Disease (Mcd) -Symptom Scale (Mcd-Ss)- Development and Validation of A Patient-Reported Outcome (Pro) Measure for An Ultra-Orphan Disease

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Chronic Lumbosciatic Syndrome in the Slovak Republic

    Nov 1, 2014, 00:00

  • RD Investments, Intangible Capital and Profitability in the Pharmaceutical Industry

    Nov 1, 2014, 00:00

  • Use of Medication Reminders in Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis- A Population-Based Study

    Nov 1, 2014, 00:00

  • Coverage With Evidence Development Activities Around The World- An Environment Scan

    Nov 1, 2014, 00:00

  • Validating A Model To Predict Disease Progression Outcomes In Patients With COPD

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Umeclidinium Bromide Compared to Tiotropium Bromide for Symptomatic Patients with COPD in the UK

    Nov 1, 2014, 00:00

  • Budget Impact Evaluation Of Treatment With A Low Protein Diet And Ketoanalogues Of Essential Aminoacids For Predialysis Patients In Russian Federation

    Nov 1, 2014, 00:00

  • Epidemiology and Direct Health Care Costs of Diabetic Retinopathy- Results From a Population-Based Study

    Nov 1, 2014, 00:00

  • Burden Of Hospitalizations Related To Chronic Hepatitis C In Fran Evolution Between 2009 And 2012

    Nov 1, 2014, 00:00

  • Disease Burden of Multiple Myeloma in China

    Nov 1, 2014, 00:00

  • Analysis of Volume and Structure of Oral Antidiabetic Drugs Consumption in Ukraine

    Nov 1, 2014, 00:00

  • Preliminary Assessment of the Cost of Treatment for Chronic Hepatitis C Virus Infections with Sofosbuvir and First Generation Antivirals Across Eight Countries

    Nov 1, 2014, 00:00

  • Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France

    Nov 1, 2014, 00:00

  • An Evaluation of the Performance of Eq-5d- A Review of Reviews of Psychometric Properties

    Nov 1, 2014, 00:00

  • Comparison Of Iqwig and G-BA Benefit Ratings in Oncology

    Nov 1, 2014, 00:00

  • Quality Assessment of Controlled Trials Evaluating Chinese Herbal Medicine in Patients With Rheumatoid Arthritis- A Systematic Review

    Nov 1, 2014, 00:00

  • The Health Service and Economic Impact of Glucagon Rescue Administration During Severe Hypoglycemic Events

    Nov 1, 2014, 00:00

  • A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefit ...

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Medication use Among Young College Students During Menstrual Cycle

    Nov 1, 2014, 00:00

  • Image-Guided Navigation Systems (IGNS) Improve Accuracy of Catheter Placement in Shunted Hydrocephalus Patients

    Nov 1, 2014, 00:00

  • Inhaled Anticholinergics and Risk for Acute Urinary Retention- A Case-Crossover and Case-Time-Control Study

    Nov 1, 2014, 00:00

  • Sources of Information and Pharmacists' Knowledge Regarding Rare Diseases and Orphan Drugs- Cross-Sectional Study In Serbia

    Nov 1, 2014, 00:00

  • Cost-Minimization and Budget-Impact Analysis of Fixed-Dose Combination Inhalers in Treatment of Copd in Slovenia

    Nov 1, 2014, 00:00

  • Treatment Patterns and Health Care Costs in Patients with Schizophrenia Initiating with First- or Second-Generation Antipsychotic- Results from a Japanese Claims Database Analysis

    Nov 1, 2014, 00:00

  • Cost Related to the Waiting List of Patients With Vertebral Malformation

    Nov 1, 2014, 00:00

  • Assessing the Translatability of the Term “Frustrated”

    Nov 1, 2014, 00:00

  • Estimation of the Cost of Childhood Asthma in Turkey

    Nov 1, 2014, 00:00

  • Financial Implications to Taiwan Health System from Changing the Dialysis Modality Mix

    Nov 1, 2014, 00:00

  • labour induction with prostaglandins- what works best? A systematic review, network meta-analysis and cost-effectiveness analysis

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors- Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK

    Nov 1, 2014, 00:00

  • Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Regulatory Approval To Patient Access, An Evaluation of Eu5 And Us National Timing Differences- An Update

    Nov 1, 2014, 00:00

  • The Valuation of EQ-5D-5L Health States in Korea

    Nov 1, 2014, 00:00

  • Sequential Combination of Chemotherapy With Egfr-Tki As The First-Line Treatment for Unselected Patients With Advanced Non-Small Cell Lung Cancer- Systematic Review of Randomized Controlled Trials

    Nov 1, 2014, 00:00

  • The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer – A Systematic Review

    Nov 1, 2014, 00:00

  • Economic Burden of Intravenous Iron Products In Public Hospitals of Paris and Impact of Their New Hospital-Restricted Status

    Nov 1, 2014, 00:00

  • Instructions for Authors

    Nov 1, 2014, 00:00

  • Construct Validity of SF-6D Health State Utility Values in an Employed Population

    Nov 1, 2014, 00:00

  • Burden of Lupus Nephritis (Ln) Among Patients Managed In Routine Clinical Practices In Europe (Eu)

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Education in Brazilian Schools of Pharmacy

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France

    Nov 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100 (current)
  • »